Summary statement on screening for prostate cancer in Europe-Reference-Cited by-同舟云学术

Summary statement on screening for prostate cancer in Europe

Published:2017-10-25 Issue:4 Volume:142 Page:741-746
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Heijnsdijk Eveline A.M.¹^ORCID,Bangma Chris H.²,Borràs Josep M.³,de Carvalho Tiago M.¹,Castells Xavier⁴,Eklund Martin⁵,Espinàs Josep A.³,Graefen Markus⁶,Grönberg Henrik⁵,Lansdorp-Vogelaar Iris¹,Leeuwen Pim J. van²,Nelen Vera⁷,Recker Franz⁸,Roobol Monique J.²,Vandenbulcke Pieter⁹,de Koning Harry J.¹

Affiliation:

1. Department of Public Health; Erasmus Medical Center, Wytemaweg 80; CN Rotterdam 3015 The Netherlands

2. Department of Urology; Erasmus Medical Center, Wytemaweg 80; CN Rotterdam 3015 The Netherlands

3. Department of Health; Catalan Institute of Oncology, Avinguda de la Granvia de l'Hospitalet 199-203; Barcelona 08908 Spain

4. Department of Epidemiology and Evaluation; IMIM (Hospital del Mar Medical Research Institute), Passeig Marítim, 25-29; Barcelona 08003 Spain

5. Department of medical epidemiology and biostatistics; Karolinska Institutet, Karolinska vägen; Solna Stockholm 171 76 Sweden

6. Martini-Clinic, Prostate Cancer Center, University Medical Center Hamburg-Eppendorf, Martinistrasse 52 Building O43; Hamburg 20246 Germany

7. Provinciaal Instituut voor Hygiëne, Kronenburgstraat 45; Antwerp 2000 Belgium

8. Department of Urology; Kantonsspital Aarau, Tellstrasse 25; Aarau 5001 Switzerland

9. Agentschap Zorg en gezondheid, Lange Kievitstraat 111-113; Antwerp 2018 Belgium

Funder

CANCON (Cancer Control Joint Action)

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference50 articles.

1. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012;Ferlay;Int J Cancer,2015

2. Screening for prostate cancer: an updated Cochrane systematic review;Ilic;BJU Int,2011

3. Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up;Schröder;Lancet,2014

4. Extended mortality results for prostate cancer screening in the PLCO trial with median follow-up of 15 years;Pinsky;Cancer,2017

5. Prostate cancer screening in the Prostate, Lung, Colorectal and Ovarian cancer screening trial: update on findings from the initial four rounds of screening in a randomized trial;Grubb;BJU Int,2008

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Navigating through the Controversies and Emerging Paradigms in Early Detection of Prostate Cancer: Bridging the Gap from Classic RCTs to Modern Population-Based Pilot Programs;Journal of Personalized Medicine;2023-12-01

2. Modified Citrus Pectin Treatment in Non-Metastatic Biochemically Relapsed Prostate Cancer: Long-Term Results of a Prospective Phase II Study;Nutrients;2023-08-11

3. Impact of PSA testing on secondary care costs in England and Wales: estimates from the Cluster randomised triAl of PSA testing for Prostate cancer (CAP);BMC Health Services Research;2023-06-09

4. Total Prostate Specific Antigen in Prostate Cancer Screening in Hyperglycemic Individuals;Clinical Genitourinary Cancer;2023-04

5. Predicting biochemical recurrence of prostate cancer with artificial intelligence;Communications Medicine;2022-06-08